All Fields
Computer Science
Medicine
FAQ
Contact
Sign in
CGS 30440
Â
National Institutes of Health
Topic mentions per year
Topic mentions per year
1997-2008
0
1
1997
2008
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
Qian Pu
,
Pascal Brassard
,
+4 authors
Ernesto L. Schiffrin
Journal of hypertension
2008
BACKGROUND The association of an angiotensin-converting enzyme inhibitor (ACEI) with a neutral endopeptidase inhibitor (NEPI) has…Â
(More)
Is this relevant?
1999
1999
CGS 30440: A Dual Inhibitor of Angiotensin-Converting Enzyme and Neutral
Endopeptidase
,
David S. Cohen
,
+4 authors
Ricardo E. Chatelain
1999
For nearly two decades, angiotensin converting enzyme (ACE) inhibitors have been used in the management of hypertension and as…Â
(More)
Is this relevant?
1998
1998
Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11.
Rémi Chatelain
,
Rajesh Ghai
,
+5 authors
Corby A Fink
The Journal of pharmacology and experimental…
1998
Dual angiotensin-converting enzyme (ACE)/neutral endopeptidase (NEP) inhibitors, by decreasing angiotensin-II production and by…Â
(More)
Is this relevant?
1998
1998
Protective effects of CGS 30440, a combined angiotensin-converting enzyme inhibitor and neutral endopeptidase inhibitor, in a model of chronic renal failure.
D. S. Cohen
,
Jürg Mathis
,
Richard A Dotson
,
S R Graybill
,
N J Wosu
Journal of cardiovascular pharmacology
1998
The purpose of these studies was to compare the effects of CGS 30440 (CGS), a dual angiotensin-converting enzyme inhibitor (ACEI…Â
(More)
Is this relevant?
1998
1998
Antihypertensive and Natriuretic Effects of CGS 30440, a Dual Inhibitor of Angiotensin-Converting Enzyme and Neutral
Endopeptidase
,
Ricardo E. Chatelain
,
+6 authors
Cynthia A. Fink
1998
Dual angiotensin-converting enzyme (ACE)/neutral endopeptidase (NEP) inhibitors, by decreasing angiotensin-II production and by…Â
(More)
Is this relevant?
1997
1997
Effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, CGS 30440, on blood pressure and cardiac hypertrophy in spontaneously hypertensive rats.
R. L. Webb
,
Mats Abramson
,
Michael E Beil
,
Luigi Odorico
,
Rémi Chatelain
Journal of cardiovascular pharmacology
1997
This study examined the long-term effects of CGS 30440 on blood pressure, heart rate, cardiac hypertrophy, and urinary parameters…Â
(More)
Is this relevant?